clinical trial · NCT07587723
A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
Immune Thrombocytopenia
brief summary
This study aims to describe the treatment patterns and clinical outcomes of treatment with eltrombopag in primary immune thrombocytopenia (ITP) patients treated with prior corticosteroid therapy. This study will use secondary data provided by health care professionals (HCPs) for a sample of primary ITP patients, and primary data from a structured HCP survey. Data will be collected from HCPs working in various clinical centers across the United States (US), United Kingdom (UK), and Germany.
started
Jun 23, 2026
primary completion
Sep 29, 2028
completion
Sep 29, 2028
last updated
Jun 15, 2026
official title
Real-world Treatment Patterns and Outcomes of Eltrombopag in Patients With Primary Immune Thrombocytopenia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol